Add BrightSurf on Google Email

Triple chemotherapy combination improves metastatic colorectal cancer outcomes

A triple drug combination of irinotecan, cetuximab, and vemurafenib has shown better tumor response rates and longer cancer-free periods compared to a two-drug combination in patients with metastatic colorectal cancer. The treatment targets the BRAF protein directly and blocks cancer growth by targeting epidermal growth factor receptor.

SourceSWOG·JournalJournal of Clinical Oncology·DateDec 23, 2020

A comprehensive review of early-onset colorectal SEER data is the first to specifically assess adeno

Researchers analyzed SEER 18 data and found adenocarcinomas to be the predominant cancer subtype in screening, surveillance, and prevention. The study also revealed that carcinoid tumors are increasing at a faster rate than adenocarcinomas, but adenocarcinomas are still steadily increasing in most early-onset subgroups.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateDec 14, 2020

Uniquely human gene may drive numerous cancers

Researchers discovered that a high proportion of advanced carcinomas carry a mutant form of the Siglec-XII protein, which is rarely expressed in normal humans. This finding may explain why humans are more prone to aggressive cancers compared to chimpanzees.

SourceWiley·JournalFASEB BioAdvances·DateDec 9, 2020

Medicaid expansion may result in earlier diagnosis of colon cancer

A new study published in the Journal of the American College of Surgeons suggests that Medicaid expansion under the Affordable Care Act may lead to earlier diagnoses of colon cancer. Researchers found improved access to care and enhanced surgical care for patients with colon cancer in states that implemented Medicaid expansion.

SourceAmerican College of Surgeons·JournalJournal of the American College of Surgeons·DateNov 23, 2020

Unlocking how cellular proteins control cancer spread

A McGill-led study unlocks the behavior of an enzyme involved in cancer cell spread, revealing a delicate interaction between PRL3 and magnesium transport proteins crucial to colorectal cancer growth. This finding calls into question long-standing hypotheses about PRL3's role in cancer spread.

SourceMcGill University·JournalJournal of Biological Chemistry·DateAug 12, 2020

Roadmap to reducing colorectal cancer deaths

A new model of screening combines better risk assessment, noninvasive testing options, and targeted referrals for colonoscopy to save more lives. The American Gastroenterological Association proposes a universal approach to screening that reaches more people and offers alternatives to colonoscopy.

SourceRush University Medical Center·JournalClinical Gastroenterology and Hepatology·DateAug 3, 2020

Night-time exposure to blue light associated with increased risk of colorectal cancer

A new study published in Epidemiology found that night-time exposure to outdoor artificial light, especially blue light, may increase the risk of colorectal cancer. The research analyzed data from over 2,000 adults and found a 60% higher risk of developing colorectal cancer among those with the highest exposures to blue light.

Discovery of key protein behind cancer relapse and progression can lead to new therapies

The study reveals that low levels of MBNL1 protein are associated with poor overall survival in various common cancers. Blocking the JNK protein can reverse this mechanism, providing a potential biomarker for selecting patients for treatment. Researchers plan to investigate MBNL1's role in colorectal cancer and explore anti-JNK therapies.

SourceDuke-NUS Medical School·JournalProceedings of the National Academy of Sciences·DateJun 30, 2020

A combo of fasting plus vitamin C is effective for hard-to-treat cancers, study shows

A combination of fasting-mimicking diet and vitamin C has been found to delay tumor progression and even cause disease regression in multiple mouse models of colorectal cancer. The treatment works by regulating iron levels and molecular mechanisms involved in oxidative stress, making it a safer alternative to toxic treatments.

SourceUniversity of Southern California·JournalNature Communications·DateMay 12, 2020

Large population study links blood infection with certain bacteria to increased risk of colorectal cancer

A large population study found a significant association between blood infections with anaerobic bacteria and an increased risk of developing colorectal cancer. The study revealed that infections with specific bacteria, such as Clostridium septicum and Bacteroides ovatus, were linked to a substantial increased risk of CRC.

Doctors group sues California for failing to add processed meat to state carcinogen list

A doctors' group is suing California for neglecting to add processed meat, such as hot dogs and bacon, to the state's cancer-causing substances list under Proposition 65. This move comes after experts classified consumption of processed meat as carcinogenic to humans, increasing risks of colorectal, breast, prostate, pancreatic, and ov...